Keyphrases
Adjuvant Bisphosphonates
14%
Adverse Events
14%
Bisphosphonates
100%
Breast Cancer Treatment
100%
Chemotherapy
28%
Cochrane Library
14%
Conference Proceedings
14%
Disease-free Survival
57%
Early Breast Cancer
28%
Effects on Survival
100%
Free Relatives
14%
Hazard Ratio
71%
Inclusion Criteria
14%
MEDLINE
14%
Menopausal Status
14%
Meta-analysis
100%
Meta-regression
28%
Negative Association
14%
Negatively Associated
14%
Neoadjuvant Setting
100%
Overall Survival
42%
Postmenopausal Patients
14%
Randomized Controlled Trial
42%
Relative Risk
14%
Significant Benefit
14%
Survival Risk
14%
Systematic Meta-analysis
100%
Therapy Effect
100%
Nursing and Health Professions
Adverse Event
12%
Bisphosphonic Acid Derivative
100%
Breast Cancer
100%
Cancer Therapy
100%
Cochrane Library
12%
Disease Free Survival
50%
Hazard Ratio
62%
Meta Analysis
100%
Overall Survival
37%
Systematic Review
100%
Therapy Effect
100%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
12%
Bisphosphonic Acid Derivative
100%
Breast Cancer
100%
Chemotherapy
25%
Disease Free Survival
50%
Overall Survival
37%
Randomized Controlled Trial
37%
Biochemistry, Genetics and Molecular Biology
Cochrane Library
25%
Disease Free Survival
100%
Overall Survival
75%
Randomized Controlled Trial
75%